Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

CJC-1295 Dosage Guide: Expert Protocols for 2026

The Definitive CJC-1295 Dosage Guide for Today's Researcher In the sprawling landscape of peptide research, clarity is everything. By 2026, the sheer volume of information—and misinformation—can feel overwhelming, making it difficult for even seasoned research

The Definitive CJC-1295 Dosage Guide for Today's Researcher

In the sprawling landscape of peptide research, clarity is everything. By 2026, the sheer volume of information—and misinformation—can feel overwhelming, making it difficult for even seasoned researchers to establish reliable protocols. That’s where we come in. Our team at Real Peptides has spent years working with these compounds, and we've seen firsthand how a meticulous approach to dosing can be the difference between groundbreaking results and a stalled project. This isn't just another article; it's our comprehensive CJC-1295 dosage guide, built from experience and a deep understanding of the science.

Let’s be honest, the stakes are high. When you're investing time, resources, and intellectual energy into a study, you need every variable to be controlled. Dosage is arguably the most critical variable of them all. An incorrect protocol doesn't just skew results; it can invalidate an entire line of inquiry. That’s why we’ve put together this CJC-1295 dosage guide—to give you the foundational knowledge you need to design and execute your research with confidence. We're going to break down everything from the different forms of CJC-1295 to reconstitution, stacking, and safety considerations.

First, What Exactly is CJC-1295?

Before we can even begin to discuss a CJC-1295 dosage guide, we have to establish what we're talking about. This is crucial because 'CJC-1295' is often used as a catch-all term for two distinctly different peptides. Getting this wrong is the first and most catastrophic mistake a researcher can make. The difference lies in something called Drug Affinity Complex, or DAC.

CJC-1295 without DAC (also known as Mod GRF 1-29): This is the original, short-acting version of the peptide. It's a synthetic analogue of growth hormone-releasing hormone (GHRH). When administered, it causes a short, sharp pulse of growth hormone from the pituitary gland, mimicking the body's natural patterns. Its half-life is very short, typically under 30 minutes. This is a critical detail for any CJC-1295 dosage guide, as it dictates a much higher frequency of administration. Our high-purity CJC 1295 (no Dac) is a prime example of this compound, designed for researchers who require precise, pulsatile GH release in their studies.

CJC-1295 with DAC: This version has the DAC component added, which allows it to bind to albumin in the blood. This simple addition dramatically extends its half-life to about 8 days. Instead of a short pulse, it creates a sustained, elevated baseline of growth hormone. This 'bleed' effect is fundamentally different from the pulsatile release of its DAC-free counterpart. An effective CJC-1295 dosage guide must treat these two compounds as entirely separate entities.

Our team has found that the vast majority of modern research protocols, especially those focused on mimicking natural physiological rhythms for applications in Longevity Research, utilize Mod GRF 1-29 (no DAC). The ability to control the timing of GH pulses is invaluable. For the remainder of this guide, we'll primarily focus on Mod GRF 1-29, as it's the more nuanced and commonly studied variant, though we will provide protocols for both.

The Non-Negotiable Importance of Purity

You can have the most impeccable CJC-1295 dosage guide in the world, but if your source material is impure, your results will be meaningless. It’s that simple. Contaminants, incorrect peptide sequences, or low concentrations can completely derail a study. This is a non-negotiable element of good science. We've seen it happen. A research team follows a perfect protocol but gets inconsistent data, only to later discover their peptide source was unreliable.

This is why at Real Peptides, we are relentless about quality. Our small-batch synthesis process ensures that every vial meets exacting standards for purity and sequence accuracy. When your research demands precision, you need a partner who can guarantee the integrity of your tools. A proper CJC-1295 dosage guide is only as good as the peptide it's used with.

CJC-1295 Dosage Guide: Mod GRF 1-29 (No DAC)

Alright, let's get into the specifics. This is the core of our CJC-1295 dosage guide. Because Mod GRF 1-29 has such a short half-life, the goal is to administer it at times that align with the body's natural growth hormone pulses, primarily upon waking, post-workout, or before bed.

Standard Research Dosage: The widely accepted and effective dosage for Mod GRF 1-29 is 100 micrograms (mcg) per injection.

Frequency of Administration: Due to its short action, it's typically administered 1 to 3 times per day.

Let’s break down what those frequencies look like in practice:

1x Per Day: For general wellness or anti-aging research models, a single 100mcg injection before bed is a common starting point. This timing leverages the body's largest natural GH pulse, which occurs during deep sleep.

2x Per Day: For studies focused on Fat Loss & Metabolic Health Bundle or body composition, administering 100mcg upon waking and another 100mcg before bed is often employed. The morning dose should be given on an empty stomach.

3x Per Day: This is the most intensive protocol, usually reserved for advanced Performance & Recovery Research. It involves 100mcg upon waking, 100mcg post-workout, and 100mcg before bed. This schedule maximizes the number of GH pulses throughout the day.

Following this part of the CJC-1295 dosage guide is paramount for achieving consistent results. Deviating from the 100mcg dose can lead to pituitary desensitization, which is counterproductive. More is not better here. The goal is to stimulate a natural-sized pulse, not to overwhelm the system. This nuanced understanding is a cornerstone of any effective CJC-1295 dosage guide.

The Power of Stacking: CJC-1295 and Ipamorelin

No CJC-1295 dosage guide would be complete without discussing stacking. While CJC-1295 (Mod GRF 1-29) is a GHRH, it works synergistically with another class of peptides called Growth Hormone Releasing Peptides (GHRPs). The most popular and, in our experience, most effective pairing is with Ipamorelin.

Think of it like this: CJC-1295 tells the pituitary how much growth hormone to release, while Ipamorelin tells it to release it. When used together, they create a stronger, more significant GH pulse than either could alone, while still preserving the natural pulsatile rhythm. It's a powerful synergy. Our experience shows that this approach, which we've refined over years, delivers real results in research settings. This is why we offer a convenient, pre-mixed CJC-1295 + Ipamorelin (5mg/5mg) blend for researchers who need reliability and simplicity.

When using this stack, the dosing protocol remains remarkably similar:

CJC-1295 (Mod GRF 1-29): 100mcg

Ipamorelin: 100mcg

These are administered together in the same syringe, following the same 1-3 times per day frequency outlined in the CJC-1295 dosage guide above. This combination is a staple in many studies, from Muscle Building Research to protocols focused on recovery, such as those that might also explore our Healing & Total Recovery Bundle. Other GHRPs like GHRP-2 or GHRP-6 can also be used, but Ipamorelin is often preferred due to its selectivity—it doesn't significantly impact cortisol or prolactin levels.

CJC-1295 Dosage Guide: With DAC Variant

Now, for the long-acting version. Because CJC-1295 with DAC has a half-life of around 8 days, the dosing strategy is completely different. This is a critical distinction in this CJC-1295 dosage guide.

Instead of daily injections to create pulses, the goal here is to maintain a steady, elevated level of GH. This is sometimes referred to as a 'GH bleed.'

Standard Research Dosage: The typical dose is between 1000mcg (1mg) and 2000mcg (2mg) per week.

Frequency of Administration: This weekly total is usually administered in 1 or 2 injections. For example, a 2mg weekly protocol could be a single 2mg injection or two separate 1mg injections on different days (e.g., Monday and Thursday).

We can't stress this enough: do not confuse the protocols. Administering the DAC version daily at 100mcg would be an incorrect and potentially problematic application. Adhering to the specific section of the CJC-1295 dosage guide that matches your compound is absolutely essential for safety and data integrity.

Reconstitution: A Practical Step-by-Step Guide

Your peptide will arrive as a lyophilized (freeze-dried) powder. To use it, you must reconstitute it with a sterile solvent. This process is delicate and requires precision. Messing it up can damage the fragile peptide chains.

Here's what our lab team recommends:

Gather Your Supplies: You'll need your vial of CJC-1295, a vial of Bacteriostatic Reconstitution Water (bac), an alcohol swab, and an insulin syringe for mixing.

Prepare the Vials: Remove the plastic caps from both vials. Gently wipe the rubber stoppers with an alcohol swab and let them air dry.

Draw the Water: Using the syringe, draw up the required amount of bacteriostatic water. The amount will depend on the vial size and your desired concentration. For a 2mg vial of CJC-1295, using 1mL or 2mL of water is common. Using 2mL makes the math a bit easier: every 10 units on a 1mL insulin syringe will equal 100mcg of peptide.

Inject the Water Slowly: Insert the needle into the CJC-1295 vial, angling it so the water runs down the side of the glass wall. Do not shoot the water directly onto the powder. This can damage the peptide.

Mix Gently: Once the water is in, gently swirl the vial or roll it between your hands. Do not shake it. The powder should dissolve completely, leaving a clear liquid.

Storage: Once reconstituted, the peptide must be stored in the refrigerator. It's generally stable for several weeks when refrigerated.

This procedure is a vital component of any trustworthy CJC-1295 dosage guide. Proper handling ensures the viability of the compound you're working with, which is foundational for reliable research. We've seen more studies compromised by improper handling than by almost any other factor. This is why a good CJC-1295 dosage guide must include these practical steps.

Sample Research Protocol Comparison

To make this CJC-1295 dosage guide even more practical, we've created a table outlining different research objectives and corresponding sample protocols. This is for informational purposes to illustrate how dosages can be adapted for different study designs.

Anti-Aging / Wellness

Mod GRF + Ipamorelin

100mcg / 100mcg

1x (Before Bed)

Focuses on leveraging the natural nocturnal GH pulse for recovery.

Body Composition / Fat Loss

2x (AM/PM)

Requires injections on an empty stomach to avoid blunting GH release.

Athletic Performance

3x (AM/Post-Workout/PM)

Most intensive protocol. Post-workout timing is critical for recovery.

Sustained GH Elevation

CJC-1295 with DAC

1000mcg (1mg)

2x per Week

Fundamentally different goal; creates a 'bleed' rather than a 'pulse'.

This table should serve as a useful reference as you explore our CJC-1295 dosage guide. Remember, these are illustrative examples, and every research protocol should be designed with specific endpoints in mind. You can Explore High-Purity Research Peptides on our website to find the tools you need for your specific lab work.

Potential Side Effects and Safety in Research

No expert CJC-1295 dosage guide would be complete without a transparent discussion of safety. When used in controlled research settings at appropriate dosages, CJC-1295 is generally observed to have a favorable safety profile. However, potential side effects can occur and should be monitored.

These can include:

Injection Site Reactions: Redness, itching, or slight pain at the injection site is the most common side effect. This is usually transient.

Head Rush or Flushing: A temporary feeling of warmth or a slight head rush can occur shortly after injection as the peptide takes effect.

Water Retention: Some degree of water retention, particularly in the hands and feet, can be noted, especially at the beginning of a protocol.

Tingling or Numbness: Carpal tunnel-like symptoms can occur, typically associated with higher levels of growth hormone.

Tiredness: An increase in tiredness can be a sign that GH levels are elevated, especially when first starting a protocol.

Our team has observed that most of these effects are dose-dependent and often subside as the research subject acclimates. The key is adherence to a sensible CJC-1295 dosage guide. Overdosing is what typically leads to more pronounced side effects. It’s another reason why starting with a conservative protocol and using high-purity peptides is the most professional and responsible approach. The goal is to stimulate a physiological response, not an overwhelming pharmacological one. And that's the core philosophy behind this entire CJC-1295 dosage guide.

As you embark on your research, remember that precision is your greatest asset. From the quality of your peptides to the accuracy of your measurements, every detail matters. We hope this comprehensive CJC-1295 dosage guide provides the clarity and confidence you need to move your work forward in 2026 and beyond. Sourcing the right materials is the first step, and we encourage you to Find the Right Peptide Tools for Your Lab with a supplier you can trust.

Frequently Asked Questions

The key difference is the half-life. CJC-1295 without DAC (Mod GRF 1-29) has a short half-life of under 30 minutes, creating a natural pulse of GH. The ‘with DAC’ version has a half-life of about 8 days, creating a sustained elevation of GH. This is a critical distinction in any CJC-1295 dosage guide.

Our experience and existing research show that 100mcg is the saturation dose for Mod GRF 1-29. This means it fully stimulates a natural-sized growth hormone pulse from the pituitary. Using more doesn’t create a larger pulse and can lead to desensitization.

Research protocols vary, but a common cycle length is 12 to 16 weeks. Some long-term anti-aging studies may extend longer. It’s crucial to design the study with clear start and end points.

Yes, absolutely. Both carbohydrates and fats can blunt the growth hormone release stimulated by CJC-1295. For best results, injections should be done at least one hour before a meal or two hours after a meal.

We strongly advise against this. Once reconstituted, the peptide is fragile and most stable when stored in its sterile vial in the refrigerator. Pre-loading syringes exposes the peptide to plastic and potential instability over time, which can degrade its potency.

The optimal times align with the body’s natural GH pulses. This includes upon waking, post-workout, and, most importantly, right before bed to amplify the large GH pulse that occurs during deep sleep. A solid CJC-1295 dosage guide will always emphasize timing.

Properly reconstituted and refrigerated CJC-1295 should remain a clear liquid. If it becomes cloudy, discolored, or you see particulates, it should be discarded immediately. This is why starting with high-purity material is so important.

Stacking CJC-1295 (a GHRH) with Ipamorelin (a GHRP) creates a powerful synergistic effect. CJC-1295 determines the size of the GH pulse, while Ipamorelin signals its release, resulting in a much stronger pulse than either could achieve alone.

Yes, another common GHRH used in research is Sermorelin. It functions very similarly to Mod GRF 1-29, also consisting of the first 29 amino acids of GHRH. Our team often sees researchers compare the effects of [Sermorelin](https://www.realpeptides.co/products/sermorelin/) and CJC-1295 in their studies.

Unlike the administration of exogenous HGH, using a GHRH like CJC-1295 stimulates the body’s own pituitary gland. It works within the natural feedback loops, so it doesn’t cause the shutdown associated with direct hormone replacement. This is a significant advantage in many research contexts.

For a 5mg vial, a common practice is to use 2.5mL of bacteriostatic water. This creates a simple concentration of 2mg per mL, making it easier to draw accurate 100mcg doses. Always double-check your math before drawing a dose.

Peptides are complex, fragile protein chains. Shooting the reconstitution water directly onto the lyophilized powder can shear these chains apart through force, destroying the molecule. Running the water gently down the side of the glass prevents this damage.

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

DOSAGE SOURCE

Dosage Protocols

No FDA-approved dosing guidelines exist for CJC-1295. The following protocols are derived from clinical research and community reports.
SIDE EFFECTS

Adverse Effect Profile and Safety Considerations

The safety profile of CJC-1295 has been evaluated in multiple clinical trials involving healthy volunteers and patient populations. Understanding the spectrum of potential adverse effects, their frequency, and management strategies is essential for appropriate clinical application and risk-benefit assessment.
02

Question drills

Open a question for its connected answer.

01What If Your Lab Doesn't Have Access to Primary Pituitary Cultures?+

Use GH3 cells for screening and mechanistic work, but validate key findings in an ex vivo system. Rat pituitary explants cultured in perifusion chambers preserve tissue architecture and receptor co-expression without requiring primary cell isolation. Alternatively, use a lower passage number of RC-4B/C cells (passages 5–15) before receptor density drifts too far from native levels. Acknowledge the model limitation in your methods section. Overexpressed receptors inflate potency estimates, so report EC50 values as

SOURCE / realpeptides.co ↗
02What If the Vial Looks Cloudy After Being Left Out?+

Discard it immediately. Cloudiness indicates either bacterial contamination or peptide aggregation. Both render the solution unusable. Aggregated CJC-1295 cannot be reversed by refrigeration. Contaminated solutions pose sterility risks if used in any research protocol. Cloudiness is a late-stage degradation signal: by the time you see it, the peptide has been compromised for days. Our experience across hundreds of peptide shipments confirms this. Visual changes always lag behind molecular degradation.

SOURCE / realpeptides.co ↗
03What If Protein Synthesis Rates Increase But Muscle Mass Doesn't?+

Protein synthesis must exceed protein breakdown (muscle protein balance must be positive). CJC-1295 downstream effects elevate synthesis rates, but if dietary protein intake is below 1.6g/kg body weight or leucine intake per meal is below 2.5–3g, the mTOR activation triggered by IGF-1 cannot be fully realized. Resistance training or mechanical loading also amplifies the anabolic response. CJC-1295 potentiates muscle growth but does not replace the mechanical stimulus entirely.

SOURCE / realpeptides.co ↗
04What If Reconstitution Uses Standard Sterile Water Instead of Bacteriostatic Water?+

Reconstitute CJC-1295 with bacteriostatic water containing 0.9% benzyl alcohol. Standard sterile water lacks antimicrobial preservation, allowing bacterial contamination that degrades the peptide within 48–72 hours at refrigeration temperature. Bacterial proteases cleave peptide bonds, destroying the DAC modification and eliminating the extended half-life. Contaminated solutions lose transcriptional activity rapidly: growth hormone mRNA upregulation drops to <50% of expected levels by day three. Bacteriostatic water extends sterile shelf life to 28 days at 2–8°C, preserving full receptor binding affinity and transcriptional potency throughout the usage window.

SOURCE / realpeptides.co ↗
05What If I'm seeing inconsistent results with CJC-1295 across different cohorts — what's the most common protocol error?+

Dose timing relative to feeding state. CJC-1295's albumin-binding mechanism is unaffected by fasting, but GH release itself is blunted by hyperglycemia and elevated free fatty acids. If subjects are dosed in a fed state, basal insulin suppresses GH secretion even when the GHRH receptor is activated. Standardize dosing to fasted state (minimum 4 hours post-prandial) to reduce inter-subject variability in GH response.

SOURCE / realpeptides.co ↗
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

Early Clinical Trials and Research Milestones

The initial human trials for CJC-1295 (with DAC) in the mid-2000s generated considerable excitement. Studies demonstrated its ability to significantly increase serum GH and IGF-1 levels in healthy adults, with effects lasting for several days after a single dose. These findings were published in reputable scientific journals, solidifying its place in the CJC-1295 history as a truly novel compound. Researchers observed improvements in body composition, including reductions in visceral fat and increases in lean muscle mass, even in subjects without GH deficiency. These were powerful early indicators of its potential, sparking widespread interest in its applications for various conditions. Early research also explored its safety profile. Generally, CJC-1295 was well-tolerated, with common side effects being mild and localized injection site reactions. This favorable safety data, coupled with its remarkable efficacy in extending GH release, spurred further investigation into its potential for a range of indications, from age-related GH decline to metabolic disorders. These were significant milestones in the CJC-1295 history, painting a clear picture of its robust physiological effects.

RESEARCH

Research Applications: Where CJC-1295 Shines Brightest

The utility of CJC-1295 extended half-life GH release spans a formidable range of research areas. It's not just a single-purpose compound; its sustained action makes it incredibly versatile. Metabolic Health Studies: Researchers investigating metabolic syndrome, glucose regulation, or lipid metabolism often look to GH pathways. The sustained GH release from CJC-1295 allows for longer-term observation of metabolic markers, offering clearer insights into potential interventions. We've seen significant interest in this area, particularly as global metabolic health challenges grow in 2026. Muscle Growth and Repair: For studies focused on muscle anabolism, sarcopenia, or recovery from injury, the steady, physiological elevation of GH can be incredibly beneficial. It supports protein synthesis and cellular repair mechanisms. Our Muscle Building Research collection provides further context on compounds relevant to this area. Longevity Research: The role of growth hormone in aging processes is a complex but fascinating field. Sustained, physiological GH release, as offered by CJC-1295 extended half-life GH release, provides an excellent tool for researchers exploring its impact on cellular senescence, tissue maintenance, and overall healthy aging. This aligns perfectly with the goals of many studies in Longevity Research. Cognitive Function and Neurological Health: Emerging research suggests GH may play a role in brain health and cognitive function. Peptides like CJC-1295 offer a stable way to study these connections without the sharp fluctuations that shorter-acting compounds might induce. This area of study is gaining traction, and we're seeing more inquiries into its potential. Bone Density and Connective Tissue Studies: GH is known to influence bone mineral density and the health of connective tissues. For long-term studies on osteoporosis models or injury recovery, the consistent support from CJC-1295 extended half-life GH release offers a stable research environment. Each of these applications benefits immensely from the predictable, prolonged action of CJC-1295 extended half-life GH release, allowing for more accurate and less labor-intensive experimental designs.

05

Product & matchup locker

Linked catalog and comparison files.

Comparison

CJC-1295 vs Other GH-Releasing Peptides

Several peptides stimulate growth hormone release through different mechanisms. Choosing the right one depends on your goal, budget, and tolerance for injection frequency. CJC-129…

Comparison

Comparison of Reconstitution Methods & Their Impact on Dosage

Different approaches to reconstitution can subtly impact how easily one can calculate CJC-1295 dosage. We've seen various methods, and while the underlying math remains constant, …